MX2021008687A - Una composicion para el tratamiento de la periodontitis y la regeneracion de la papila interdental. - Google Patents

Una composicion para el tratamiento de la periodontitis y la regeneracion de la papila interdental.

Info

Publication number
MX2021008687A
MX2021008687A MX2021008687A MX2021008687A MX2021008687A MX 2021008687 A MX2021008687 A MX 2021008687A MX 2021008687 A MX2021008687 A MX 2021008687A MX 2021008687 A MX2021008687 A MX 2021008687A MX 2021008687 A MX2021008687 A MX 2021008687A
Authority
MX
Mexico
Prior art keywords
periodontitis
regeneration
composition
treatment
therapeutic
Prior art date
Application number
MX2021008687A
Other languages
English (en)
Inventor
Giovanni Prussia
Claudia Prussia
Mastelli Giulia Cattarini
Original Assignee
Mastelli S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mastelli S R L filed Critical Mastelli S R L
Publication of MX2021008687A publication Critical patent/MX2021008687A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18

Abstract

Una composición que comprende ácido hialurónico y una mezcla de polinucleótidos que se extraen de una fuente natural, para su uso como una sustancia activa en el tratamiento terapéutico y/o cosmético para la regeneración de la papila interdental o en el tratamiento terapéutico y/o cosmético de la recesión de la papila interincisal (síndrome del triángulo negro) o en el tratamiento terapéutico y/o cosmético de la periodontitis, se describe en la presente descripción.
MX2021008687A 2019-01-24 2020-01-24 Una composicion para el tratamiento de la periodontitis y la regeneracion de la papila interdental. MX2021008687A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102019000001081A IT201900001081A1 (it) 2019-01-24 2019-01-24 Composizione per il trattamento delle parodontiti e la rigenerazione della papilla interdentale
PCT/IB2020/050567 WO2020152643A1 (en) 2019-01-24 2020-01-24 A composition for the treatment of periodontitis and regeneration of interdental papilla

Publications (1)

Publication Number Publication Date
MX2021008687A true MX2021008687A (es) 2021-11-04

Family

ID=66476710

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021008687A MX2021008687A (es) 2019-01-24 2020-01-24 Una composicion para el tratamiento de la periodontitis y la regeneracion de la papila interdental.

Country Status (19)

Country Link
US (1) US20220079974A1 (es)
EP (1) EP3914258B1 (es)
JP (1) JP2022518031A (es)
KR (1) KR20210119453A (es)
CN (1) CN113286599A (es)
AU (1) AU2020211076A1 (es)
BR (1) BR112021014177A2 (es)
CA (1) CA3124769A1 (es)
CO (1) CO2021010273A2 (es)
DK (1) DK3914258T3 (es)
FI (1) FI3914258T3 (es)
IL (1) IL285012A (es)
IT (1) IT201900001081A1 (es)
MA (1) MA54818A (es)
MX (1) MX2021008687A (es)
PL (1) PL3914258T3 (es)
UA (1) UA128021C2 (es)
WO (1) WO2020152643A1 (es)
ZA (1) ZA202104363B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210044168A (ko) * 2019-10-14 2021-04-22 손진경 필러 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842300B2 (en) 2002-07-31 2010-11-30 Dentsply International, Inc. Bone repair putty
IT1401218B1 (it) * 2010-07-14 2013-07-12 Mastelli S R L Composizione ad attivita' bio-rigenerativa, riparativa ed eutrofizzante.
JP6660469B2 (ja) * 2015-11-24 2020-03-11 ビーエムアイ コリア カンパニー リミテッド ヒアルロン酸誘導体およびｄｎａ分画物が含まれているヒアルロン酸注射用組成物およびその利用
JP2018197196A (ja) * 2017-05-23 2018-12-13 学校法人日本大学 歯周炎治療薬

Also Published As

Publication number Publication date
MA54818A (fr) 2021-12-01
CA3124769A1 (en) 2020-07-30
CO2021010273A2 (es) 2021-08-19
CN113286599A (zh) 2021-08-20
IT201900001081A1 (it) 2020-07-24
BR112021014177A2 (pt) 2021-09-21
IL285012A (en) 2021-09-30
WO2020152643A1 (en) 2020-07-30
US20220079974A1 (en) 2022-03-17
JP2022518031A (ja) 2022-03-11
EP3914258B1 (en) 2023-11-29
FI3914258T3 (fi) 2024-02-06
DK3914258T3 (da) 2024-02-12
UA128021C2 (uk) 2024-03-13
PL3914258T3 (pl) 2024-04-08
AU2020211076A1 (en) 2021-08-12
ZA202104363B (en) 2023-01-25
EP3914258A1 (en) 2021-12-01
KR20210119453A (ko) 2021-10-05

Similar Documents

Publication Publication Date Title
WO2019199861A3 (en) Hemp extract for treatment of pain in animals
EP2305276A3 (en) Processed lipoaspirate cells for use in therapy
AU2010300611A8 (en) Hematopoietic stem cells for use in the treatment of a kidney injury
PH12020551597A1 (en) Treatment of hidradenitis suppurativa using jak inhibitors
EA201590166A1 (ru) Комбинированная терапия для лечения рассеянного склероза
EP1670450A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA
MX2020009602A (es) Formulaciones de pulverizacion de epinefrina.
DE60121303D1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
SG11201906787UA (en) Injectable composition for preventing hair loss or stimulating hair growth
MX2023000187A (es) Dosificacion de vibegron para el tratamiento de vejiga sobreactiva.
AU2018282104A1 (en) Use of vibegron to treat overactive bladder
MX2020011817A (es) Metodos para tratar el linfoma.
GEP20247585B (en) Furoindazole derivatives
RU2013132566A (ru) Терапевтическое средство от грыжи межпозвоночного диска
PH12018501060A1 (en) Composition for preventing or treating hair loss comprising chemokine (c-x-c motif) ligand 1 (cxcl1) protein
MX2021008687A (es) Una composicion para el tratamiento de la periodontitis y la regeneracion de la papila interdental.
MX2023007080A (es) Metodo para el tratamiento de la fibrosis.
CR20210514A (es) USO DE REBOXETINA PARA EL TRATAMIENTO DE NARCOLEPSIA (Divisional 2021-0183)
WO2018226058A3 (ko) 콜라겐 타입 ι 및 색소 상피성 인자 펩타이드를 유효성분으로 함유하는 신생혈관질환 예방 또는 치료용 약학조성물
WO2018094023A3 (en) Cyclic dipeptides and wound healing
MX2020010747A (es) Formulaciones topicas que comprenden estroncio y metilsulfonilmetano (msm) y metodos de tratamiento.
RU2013122510A (ru) Стоматологический гель с ниосомами для лечения воспалительных и дистрофических заболеваний пародонта
CA3156680A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETT SYNDROME
MX2021008303A (es) Inhibidores de lta4h para el tratamiento de la hidradenitis supurativa.
BR112021020141A2 (pt) Combinação de chir99021 e ácido valpróico para tratamento de perda auditiva